Literature DB >> 29762084

Irritable bowel symptoms, use of healthcare, costs, sickness and disability pension benefits: A long-term population-based study.

Chalotte H Poulsen1,2, Lene F Eplov2, Carsten Hjorthøj2, Lene H Hastrup3, Marie Eliasen1, Thomas M Dantoft1, Andreas Schröder4, Torben Jørgensen1,5,6.   

Abstract

OBJECTIVES: Irritable bowel syndrome (IBS) is associated with increased healthcare use and work absenteeism. We aimed to investigate long-term use of healthcare services and social benefits across IBS symptom groups. Additionally, we estimated excess healthcare costs.
METHODS: A longitudinal population-based study comprising two 5-year follow-up studies: The Danish part of the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (Dan-MONICA) 1 (1982-1987) and Inter99 (1999-2004) recruited from the western part of Copenhagen County. The total study population ( n = 7278) was divided into symptom groups according to degree of IBS definition fulfillment at baseline and/or 5-year follow-up and was followed until 31 December 2013 in Danish central registries. Poisson regression was used for the analyses adjusting for age, sex, length of education, comorbidity, cohort membership and mental vulnerability.
RESULTS: IBS symptom groups compared to no IBS symptoms were associated with an increased number of contacts with primary and secondary healthcare, as well as weeks on sickness and disability benefits. Accounting for mental vulnerability decreased the estimates and all but two associations between IBS symptom groups and outcomes remained statistically significant. The two associations that became insignificant were contacts with psychiatric hospitals and weeks on disability pension. The excess unadjusted healthcare costs for IBS were 680 Euros per year and the overall association between symptom groups and total healthcare costs were statistically significant.
CONCLUSIONS: IBS symptoms influence the long-term use and costs of healthcare, as well as the use of social benefits in the general population. Mental vulnerability explained some, but not all, of the use of healthcare and social benefits.

Entities:  

Keywords:  Irritable bowel syndrome; healthcare costs; prognosis; sick leave

Year:  2018        PMID: 29762084     DOI: 10.1177/1403494818776168

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  8 in total

Review 1.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

2.  Effects of a comprehensive self-management intervention on extraintestinal symptoms among patients with IBS.

Authors:  Kendra J Kamp; Kristen R Weaver; LeeAnne B Sherwin; Pamela Barney; Sun-Kyung Hwang; Pei-Lin Yang; Robert L Burr; Kevin C Cain; Margaret M Heitkemper
Journal:  J Psychosom Res       Date:  2019-08-29       Impact factor: 3.006

3.  Two Gold Kiwifruit Daily for Effective Treatment of Constipation in Adults-A Randomized Clinical Trial.

Authors:  Simone B Bayer; Phoebe Heenan; Chris Frampton; Catherine L Wall; Lynley N Drummond; Nicole C Roy; Richard B Gearry
Journal:  Nutrients       Date:  2022-10-06       Impact factor: 6.706

4.  Cytokine Levels and Symptoms Among Women with Irritable Bowel Syndrome: Considering the Role of Hormonal Contraceptive Use.

Authors:  Kendra J Kamp; Claire Han; Robert J Shulman; Kevin C Cain; Pamela Barney; Mark R Opp; Lin Chang; Robert L Burr; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2020-07-17       Impact factor: 2.522

5.  Effect of Samryungbaekchul-san Combined with Otilonium Bromide on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial.

Authors:  Jin-Hyun Lee; Joong Il Kim; Myong Ki Baeg; Yun-Young Sunwoo; Kwangsun Do; Jung-Han Lee; Hye-Jung Kim; Ja Sung Choi; Jayoung Kim; Chang-Seob Seo; Hyeun-Kyoo Shin; Hyekyung Ha; Tae-Yong Park
Journal:  J Clin Med       Date:  2019-09-27       Impact factor: 4.241

6.  How to raise the interest for neurogastroenterology among young gastroenterologists?

Authors:  Chloé Melchior; Alexandre Nuzzo; Daniel Keszthelyi
Journal:  United European Gastroenterol J       Date:  2021-11-01       Impact factor: 4.623

7.  Alterations in Gut Microbiome Composition and Function in Irritable Bowel Syndrome and Increased Probiotic Abundance with Daily Supplementation.

Authors:  Joann Phan; Divya Nair; Suneer Jain; Thibaut Montagne; Demi Valeria Flores; Andre Nguyen; Summer Dietsche; Saurabh Gombar; Philip Cotter
Journal:  mSystems       Date:  2021-11-02       Impact factor: 6.496

8.  Illness perception and health care use in individuals with irritable bowel syndrome: results from an online survey.

Authors:  Juliane Schwille-Kiuntke; Solveig Lu Rüdlin; Florian Junne; Paul Enck; Katja Brenk-Franz; Stephan Zipfel; Monika A Rieger
Journal:  BMC Fam Pract       Date:  2021-07-19       Impact factor: 2.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.